Pliant Therapeutics Inc — Cash Flow (NASDAQ:PLRX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 37.27 M75.44 M94.63 M116.36 M155.5 M 158.21 M Cash from investing activities 210.87 M73.7 M150.2 M127.01 M140.34 M 171.65 M Cash from financing activities 213.21 M2.53 M226.85 M274.4 M23.12 M 672 K Free cash flow 35.74 M73.49 M92.87 M115.44 M151.66 M 157.63 M

新闻

Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration

Pliant Therapeutics首席财务官Cummings出售价值30,722美元股票

Pliant Therapeutics首席人力资源官Cheung出售价值9.6千美元股票

Pliant therapeutics CFO Cummings sells $30,722 in stock

Pliant Therapeutics CHRO Cheung sells $9.6k in stock

Pliant Therapeutics首席运营官郭敏卖出价值$8,853股份

Pliant Therapeutics任命郭敏为首席运营官

Pliant Therapeutics appoints Minnie Kuo as chief operating officer

Pliant Therapeutics, Inc. (PLRX) Presents at Piper Sandler 37th Annual Healthcare Conference - Slideshow (NASDAQ:PLRX) 2025-12-09

Pliant Therapeutics将终止首席医疗官Éric Lefebvre博士的雇佣关系

Pliant Therapeutics to end employment of chief medical officer Dr. Éric Lefebvre

Pliant Therapeutics股票因癌症药物试验结果喜人而跳涨